CVBT's research work is led by its Scientific Advisory Board. The Board consists of some of the world's leading scientists in the fields of protein biochemistry and angiogenesis:

Ralph A. Bradshaw, Ph.D.
Chair of Scientific Advisory Board

Michael Blaber, Ph.D.
Professor of Biomedical Sciences, College of Medicine, Florida State University

Thomas J. Stegmann, M.D., Ph.D.
Co-Founder, Chief Medical Officer

Kenneth A. Thomas, Ph.D.
Vice President, Research and Development

Lynne Wagoner, M.D.
Cardiologist, Greater Cincinnati Cardiovascular Consultants (GCCC)

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.